4-(2-Pyridinyl)benzaldehyde | CAS:127406-56-8

We serve 4-(2-Pyridinyl)benzaldehyde CAS:127406-56-8 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
4-(2-Pyridinyl)benzaldehyde

Chemical Name: 4-(2-Pyridinyl)benzaldehyde
CAS.NO:127406-56-8
Synonyms:
4-pyridin-2-ylbenzaldehyde
2-(4-Formylphenyl)pyridine
4-Pyridin-2-yl-benzaldehyde
4-(2-Pyridyl)benzaldehyde
4-(2-Pyridinyl)Benzaldehyde

Molecular Formula:C12H9NO
Molecular Weight:183.20600

Physical and Chemical Properties:
Density: 1.147 g / cm3
Boiling point: 340.4ºC at 760 mmHg
Melting point: 50-52 ° C (lit.)
Flash point:> 230 ° F
Refractive index: 1.614

Specification:
Appearance:white crystalline powder
Purity:≥98%
Water:≤0.5%

Packing:
 25kg  cardboard drum or according to customer specified requirements
Storage:Stored in a cool and dry well-closed container. Keep away from moisture and strong light/heat.
Application:Intermediates of Atazanavir sulfate CAS:229975-97-7
Intermediates of Atazanavir CAS:198904-31-3



Contact us for information like 4-(2-Pyridinyl)benzaldehyde chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,4-(2-Pyridinyl)Benzaldehyde physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,4-(2-Pyridyl)benzaldehyde Use and application,4-(2-Pyridinyl)benzaldehyde technical grade,usp/ep/jp grade.


Related News: Chinese President Xi Jinping vowed to tackle the spread of the virus, saying: “People’s lives and health should be given top priority and the spread of the outbreak should be resolutely curbed.”Ethyl 2-Bromoisovalerate manufacturer Chinese President Xi Jinping vowed to tackle the spread of the virus, saying: “People’s lives and health should be given top priority and the spread of the outbreak should be resolutely curbed.”6-Chloro-2-cyano-3-nitropyridine supplier In recent years, there has been a relatively concentrated concentration of intermediate companies listed on the capital market. Most of the fund-raising projects are aimed at breaking through the bottleneck of production capacity to meet growing demand, and the entire industry has shown a vigorous development momentum.Methyl 2-bromo-2-methylpropionate vendor Active pharmaceutical ingredients directly impact disease.The acquired pharmaceutical intermediates business will be renamed Corden Pharma Switzerland LLC and will operate as part of ICIG’s pharmaceutical business within the Corden Pharma platform. The companies’ goal is to close the transaction during the first quarter of 2011. Financial terms are not disclosed.